Skip to main content
SpringerLink
Log in

Klinischer Nutzen psychoneuroendokrinologischer Untersuchungen

  • Conference paper
Das Verhältnis der Psychiatrie zu ihren Nachbardisziplinen

  • 32 Accesses

Zusammenfassung

Lange vor der Entdeckung der Psychopharmaka erhoffte man durch die Erforschung hormoneller Vorgänge Grundlagen für die gesunde psychische Entwicklung zu finden. Der Schweizer Psychiater Manfred Bleuler definierte 1954 die Aufgaben dieses Forschungsgebietes, das er in Anlehnung an Laignel-Lavastine „endokrinologische Psychiatrie“nannte. Er verstand darunter die Lehre von den Zusammenhängen zwischen endokrinologischen und psychischen Krankheitserscheinungen. Besonders hervorzuheben ist, daß Bleuler die Hypothese überprüfen wollte, ob psychopathologi-sche und endokrinologische Auffälligkeiten verschiedene Seiten ein und desselben Lebensvorganges sind, oder ob sie sich gegenseitig beeinflussen. In engem Zusammenhang mit diesen ätiologisch ausgerichteten Fragen stand der Wunsch, die aus der endokrinologisch-psychiatrischen Forschung gewonnenen Erfahrungen klinisch umzusetzen. Man erwartete zu dieser Zeit Kenntnisse darüber zu erlangen, „ob und wie sich die Persönlichkeit und ihre Störungen durch das Endokrinium treffende Behandlungen beeinflussen lassen und umgekehrt“. Die Hypothese, vom Endokrinium aus die Psyche und von der Psyche aus das Endokrinium zu beeinflussen, erweckte große therapeutische Hoffnungen. Man glaubte bald, mit Hilfe von Hormontherapien manisch-depressive Patienten, Schizophrenie, Epilepsie, Neurosen, Psychopathien und andere psychische Erkrankungen heilen zu können. Auch hoffte man, die Reifung des Gesunden lenken und sein Altern verzögern zu können.

Einige der zitierten Arbeiten des Autors wurden durch die Unterstützung der Deutschen Forschungsgemeinschaft (Ho-940 1/1) ermöglicht.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • American Psychiatric Association (1980) Diagnostic and Statistic Manual of Mental Disorders (DSM-III), 3rd ed. American Psychiatric Association, Washington DC

    Google Scholar 

  • Angst J, Dobler-Mikola A (1984) The Zurich Study. II. The continuum from normal to pathological depressive mood swings. Eur Arch Psychiat Neurol Sci 234: 21 – 29

    Article  CAS  Google Scholar 

  • Arana GW, Workman RJ, Baldessarini RJ (1984) Association between low plasma levels of dexamethasone and elevated levels of Cortisol in psychiatric patients given dexamethasone. Amer J Psychiat 141: 1619–1620

    PubMed  CAS  Google Scholar 

  • Asnis GM, Sachar EJ, Halbreich U, Nathan RS, Ostrow L, Halpern FS (1981) Cortisol secretion and dexamethasone response in depression. Amer J Psychiat 138: 1218 – 1221

    PubMed  CAS  Google Scholar 

  • Baldessarini R, Finklestein S, Arana GW (1983) The predictive power of diagnostic tests and the effect of prevalence of illness. Arch Psychiat 40: 569 – 573

    Google Scholar 

  • Bardeleben U v, Holsboer F, Stalla GK, Müller OA (1985) Combined administration of human corticotropin-releasing factor and lysine vasopressin induces Cortisol escape from dexamethasone suppression in healthy subjects. Life Sciences 37:1613 – 1618

    Article  Google Scholar 

  • Bech P, Gjerris A, Anderson J (1983) The melancholia scale and the Newcastle scales: itemcombination and inter-observer reliability. Brit J Psychiat 143: 58 – 63

    Article  PubMed  CAS  Google Scholar 

  • Beckmann H, Holzmüller B, Fleckenstein P (1984) Clinical investigations into antidepressive mechanisms. II. Dexamethasone suppression test predicts response to nomifensine or amitriptyline. Acta psychiat scand 70: 342 – 353

    Article  PubMed  CAS  Google Scholar 

  • Berger M, Doerr P, Lund T, Bronisch T, Zerssen D v (1982) Neuroendocrinological and neurophysiological studies in major depressive disorders: Are there biological markers for the endogenous subtype? Biol Psychiat 17: 1217 – 1242

    PubMed  CAS  Google Scholar 

  • Berger M, Pirke KM, Doerr P, Krieg JC, Zerssen D v (1983) Influence of weight loss on the dexamethasone suppression test. Arch gen Psychiat 40: 585 – 586

    Article  PubMed  CAS  Google Scholar 

  • Berger M, Pirke KM, Doerr P, Krieg JC, Zerssen D v (1984) The limited utility of the dexamethasone supression test for the diagnostic process in psychiatry. Brit J Psychiat 145: 372–382

    Article  PubMed  CAS  Google Scholar 

  • Bleuler M (1954) I. Einleitung: Ziele, Grundlagen und Grenzen. In: Bleuler M (ed) Endokrinologische Psychiatrie. Thieme, Stuttgart, S 1–27

    Google Scholar 

  • Britton DR, Koob GF, Rivier J, Vale W (1982) Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. Life Sci 31: 363 – 367

    Article  PubMed  CAS  Google Scholar 

  • Brown WA, Johnston R, Mayfield D (1979) The 24-hour dexamethasone suppression test in a clinical setting: relationship to diagnosis, symptoms and response to treatment. Amer J Psychiat 136:543–547

    PubMed  CAS  Google Scholar 

  • Brown WA (1980) Dexamethasone suppression test identifies subtypes of depression which respond to different antidepressant. Lancet I: 928 – 929

    Google Scholar 

  • Cantwell DP, Sturzenberger S, Burroughs J, Salkin B, Green JK (1977) Anorexia nervosa, an affective disorder? Arch gen Psychiat 34: 1037–1093

    Article  Google Scholar 

  • Carroll, BJ (to be published) Dexamethasone suppression test: a review of contemporary confusion. J Clin Psychiat

    Google Scholar 

  • Carroll BJ, Schroeder K, Mukhodpadhyay S et al. (1980) Plasma dexamethasone concentrations and Cortisol suppression response in patients with endogenous depression. J Clin Endocrinol Metab 51: 433–437

    Article  PubMed  CAS  Google Scholar 

  • Carroll BJ, Feinberg M, Greden JF et al. (1981) A specific laboratory test for the diagnosis of melancholia. Arch gen Psychiat 38: 15 – 22

    Article  PubMed  CAS  Google Scholar 

  • Checkley SA (1980) Neuroendocrine tests of monoamine function in man: a review of basic theory and its application to the study of depressive illness. Psychol Med 10: 35 – 53

    Article  PubMed  CAS  Google Scholar 

  • Dewan MJ, Pandurangi AK, Boucher ML, Levy BF, Major LF (1982) Abnormal dexamethasone suppression test results in chronic schizophrenic patients. Amer J Psychiat 139:1501–1503

    PubMed  CAS  Google Scholar 

  • Evans DL, Nemeroff CB (1984) Clinical use of the dexamethasone suppression test in DSM III affective disorders. Arch gen Psychiat, submitted

    Google Scholar 

  • Extein I, Pottash ALC, Gold MS (1981) Relationship to thyrotropin-releasing hormone test and dexamethasone suppression test abnormalities in unipolar depression. Psychiat Res 4:49 – 53

    Article  CAS  Google Scholar 

  • Extein I, Pottash ALC, Gold MS, Cowdry RW (1982) Using the protirelin test to distinguish mania from schizophrenia. Arch gen Psychiat 39: 77 – 81

    Article  PubMed  CAS  Google Scholar 

  • Galen RS (1983) The predictive value of laboratory diagnoses. Bull Mol Biol Med 8:159–169

    Google Scholar 

  • Georgotas A, Stokes PE, Krakowski M, Fanelli C, Cooper T (1984) Hypothalamic-pituitary-adrenocortical function in geriatric depression: diagnostic and treatment implications. Biol Psychiat 19:685–693

    PubMed  CAS  Google Scholar 

  • Gerken A, Holsboer F (1985) Cortisol and corticosterone response after syncorticotropin in relationship to dexamethasone suppressibility of Cortisol. Psychoneuroendocrinol

    Google Scholar 

  • Gerken A, Maier W, Holsboer F (to be published) Weekly monitoring of dexamethasone suppression response in depression: its relationship to change of body weight and psychopathology. Psychoneuroendocrinol 10:261–271

    Google Scholar 

  • Gold MS, Pottasch ALC, Ryan N, Sweeney DR, Davies RK, Martin DM (1980) TRH-induced TSH response in unipolar bipolar and secondary depressions: possible utility in clinical assessment and differential diagnosis. Psychoneuroendocrinol 5: 144–155

    Article  Google Scholar 

  • Greden JF, Gardner R, King D, Grunhaus L, Kronfol Z, Carroll BJ (1983) Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility. Arch gen Psychiat 40: 493 – 500

    Article  PubMed  CAS  Google Scholar 

  • Heimann H (1979) Klinische und psychopathologische Grundlagen. In: Kisker KP, Meyer JE, Müller C, Strömgren E (eds) Psychiatrie der Gegenwart, Forschung und Praxis, Grundlagen und Methoden der Psychiatrie, Teil 1. Springer, Berlin Heidelberg New York, S 2–42

    Google Scholar 

  • Holsboer F, Bender W, Benkert O, Klein HE, Schmauss M (1980) Diagnostic value of dexamethasone suppression test in depression. Lancet I: 706

    Article  Google Scholar 

  • Holsboer F, Liebl R, Hofschuster E (1982a) Repeated dexamethasone suppression test during depressive illness. Normalization of the test result compared with clinical improvement. J Affect Dis 4: 93–101

    Article  PubMed  CAS  Google Scholar 

  • Holsboer F, Winter K, Doerr HG, Sippell WG (1982b) Dexamethasone suppression test in female patients with endogenous depression: determination of plasma corticosterone, 11-deoxycorticosterone, 11-deoxycortisol, Cortisol and cortisone. Psychoneuroendocrinol 7: 329–338

    Article  CAS  Google Scholar 

  • Holsboer F, Doerr HG, Sippell WG (1982c) Dexamethasone suppression of 11-deoxycorticosterone, corticosterone, and Cortisol in depressed female patients and normal controls. Acta psychiat scand 66: 18 – 25

    Article  PubMed  CAS  Google Scholar 

  • Holsboer F (1983) Prediction of clinical course by dexamethasone suppression test (DST) response in depressed patients — physiological and clinical construct validity of the DST —. Pharmacopsychiat 16: 186–191

    Article  CAS  Google Scholar 

  • Holsboer F, Steiger A, Maier W (1983a) Four cases of reversion to abnormal dexamethasone suppression test response as indicator of clinical relapse: a preliminary report. Biol Psychiat 18: 911–916

    PubMed  CAS  Google Scholar 

  • Holsboer F, Doerr HG, Sippell WG (1983b) Increased sensitivity of the dexamethasone suppression test in depressed female patients based on multisteroid analysis. Psychiat Res 8: 49–57

    Article  CAS  Google Scholar 

  • Holsboer F, Gerken A, Steiger A, Fass V (1984a) The mean 14.00h— 17.00h plasma Cortisol concentration and its relationship to the 1 mg dexamethasone suppression response in depressives and controls. Acta psychiat scand 69: 383 – 390

    Article  PubMed  CAS  Google Scholar 

  • Holsboer F, Haack D, Gerken A, Vecsei P (1984b) Plasma dexamethasone concentrations and differential glucocorticoid suppression response in depressives and controls. Biol Psychiat 19: 281–291

    Article  PubMed  CAS  Google Scholar 

  • Holsboer F, Philipp M, Gerken A (1984c) Dexamethasone suppression test (DST) and weight loss. Psychiat Res 13: 353–354

    Article  CAS  Google Scholar 

  • Holsboer F, Müller OA, Doerr HG et al. (1984d) ACTH and multisteroid responses to corticotropin-releasing factor in depressive illness: relationship to multisteroid responses after ACTH stimulation and dexamethasone suppression. Psychoneuroendocrinol 9: 147 – 160

    Article  CAS  Google Scholar 

  • Holsboer F, Gerken A, Steiger A, Benkert O, Müller OA, Stalla GK (1984e) Corticotropin-releasing factor induced pituitary-adrenal response in depression. Lancet I: 55

    Article  Google Scholar 

  • Holsboer F, Bardeleben U v, Gerken A, Stalla GK, Müller OA (1984f) Blunted corticotropin and normal Cortisol response to human corticotropin releasing factor (h —CRF) in depression. New Engl J Med 311: 1127

    PubMed  CAS  Google Scholar 

  • Holsboer F (1985) Die Entwicklung endokrinologischer Tests in der Depressions-Forschung am Beispiel des Dexamethason-Suppressions-Test. In: Hippius H, Matussek N (Hrsg) Advances in Pharmacotherapy. S Karger AG, Basel (Differentialtherapie der Depression — Möglichkeiten und Grenzen, Vol II, pp 101 – 119)

    Google Scholar 

  • Holsboer F, Benkert O (1985) Neuroendokrinologische und endokrinologische Forschung bei depressiven Patienten. Nervenarzt 56: 1 – 11

    PubMed  CAS  Google Scholar 

  • Holsboer F, Gerken A, Bardeleben U v, Grimm W, Stalla GK, Müller OA (1985a) Relationship between pituitary responses to human corticotropin-releasing factor and thyrotropin-releasing hormone in depressives and normal controls. Europ J Pharmacol 110: 153 – 154

    Article  CAS  Google Scholar 

  • Holsboer F, Wiedemann K, Gerken A, Boll E (to be published) The plasma dexamethasone variable in depression — test retest studies and early biophase kinetics. Psychiat Res

    Google Scholar 

  • Johnson GF, Hunt G, Kerr K, Caterson I (1984) Dexamethasone suppression test (DST) and plasma dexamethasone levels in depressed patients. Psychiat Res 13: 305 – 313

    Article  CAS  Google Scholar 

  • Kendell RE (1976) The classification of depressions: a review of contemporary confusion. Brit J Psychiat 129: 15–28

    Article  PubMed  CAS  Google Scholar 

  • King D, Dowdy S, Jack R, Gardner R, Edwards P (1982) the dexamethasone suppression test as a predictor of sleep deprivation antidepressant effect. Psychiat Res 7: 93 – 99

    Article  CAS  Google Scholar 

  • Laakmann G, Benkert O (1978) Neuroendokrinologie und Psychopharmaka. Arzneim Forsch/Drug Res 28: 1277–1280

    CAS  Google Scholar 

  • Labrie F, Giguere V, Proulx L, Lefevre G (1984) Interactions between CRF epinephrine vasopressin and glucocorticoids in the control of ACTH secretion. J Steroid Biochem 20: 153–160

    Article  PubMed  CAS  Google Scholar 

  • Langer G, Resch F, Aschauer H, Keshavan MS, Koinig G, Schönbeck G, Dittrich R (1984) TSH-response patterns to TRH stimulation may indicate therapeutic mechanisms of antidepressant and neuroleptic drugs. Neuropsychobiol 11: 213 – 218

    Article  CAS  Google Scholar 

  • Loosen PT, Prange AJ jr (1982) Serum thyrotropin response to thyrotropin-releasing hormone in psychiatric patients: a review. Amer J Psychiat 139: 405–416

    PubMed  CAS  Google Scholar 

  • Matussek N (1978) Neuroendokrinologische Untersuchungen bei depressiven Syndromen. Nervenarzt 49: 569–575

    PubMed  CAS  Google Scholar 

  • Mezey E, Kiss JZ, Skirboll LR, Goldstein M, Axelrod J (1984) Increase of corticotropinreleasing factor staining in rat paraventricular nucleus neurones by depletion of hypothalamic adrenaline. Nature 310: 140–141

    Article  PubMed  CAS  Google Scholar 

  • Morley JE (1981) Neuroendocrine control of thyrotropin secretion. Endocrine Reviews 2: 396–436

    Article  PubMed  CAS  Google Scholar 

  • Nasrallah HA, Coryell WH (1982) Dexamethasone nonsuppression predicts the antidepressant effects of sleep deprivation. Psychiat Res 6: 61 – 64

    Article  CAS  Google Scholar 

  • Peselow ED, Goldring N, Fieve RR, Wright R (1983) The dexamethasone suppression test in depressed outpatients and normal control subjects. Amer J Psychiat 140: 245 – 247

    PubMed  CAS  Google Scholar 

  • Philipp M, Maier W, Holsboer F (to be published) Psychopathological correlates of plasma Cortisol after dexamethasone suppression: a polydiagnostic approach. Psychoneuroendocrinol

    Google Scholar 

  • Re RE, Kourides IA, Ridway EC, Weintraub BD, Maloof F (1976) The effect of glucocorticoid administration on human pituitary secretion of thyrotropin and prolactin. J Clin Endocrinol Metab 43: 338–346

    Article  PubMed  CAS  Google Scholar 

  • Rubin RT, Poland RE, Blodgett ALN, Winston RA, Forster B, Carroll BJ (1980) Cortisol dynamics and dexamethasone pharmacokinetics in primary endogenous depression: preliminary findings. Progr in Psychoneuroendocrinol: 223 – 234

    Google Scholar 

  • Rush J, Giles DE, Roffwarg HP, Parker CR (1982) Sleep EEG and dexamethasone suppression test findings in outpatients with unipolar major depressive illness. Biol Psychiat 17: 327 – 341

    PubMed  CAS  Google Scholar 

  • Sachar EJ (1975) Neuroendocrine abnormalities in depressive illness. In: Sachar EJ (ed) Topics in psychoneuroendocrinology. Grune & Stratton, New York San Francisco London, p 135–156

    Google Scholar 

  • Sachar, EJ, (1978) Neuroendocrine responses to psychotropic drugs. In: Lipton MA, DiMascio A, Killam KF (eds) Psychopharmacology: a generation of progress. Raven Press, New York, p 499–507

    Google Scholar 

  • Stokes PE, Stoll PM, Koslow SH, Maas JW, Davis JM, Swann AC, Robins E (1984) Pretreatment DSt and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. Arch Gen Psychiat 41: 257 – 267

    Article  PubMed  CAS  Google Scholar 

  • Sutton RE, Koob GF, Le Moal M, Rivier J, Vale W (1982) Corticotropin releasing factor produces behavioral activation in rats. Nature 297: 331 – 333

    Article  PubMed  CAS  Google Scholar 

  • Swanson LW, Sawchenko PE, Rivier J, Vale W (1983) Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinol 36: 165 – 186

    Article  CAS  Google Scholar 

  • Thomas EB, Levine S, Arnold WJ (1968) Effects of maternal deprivation and incubations rearing upon adrenocortical activity in the adult rat. Develop Psychobiol 1: 21–23

    Article  Google Scholar 

  • Trachsler E, Höchli D, Luckner N v, Woggon B (1985) Dexamethasone suppression test before and after partial sleep deprivation in depressed schizophenic and schizoaffective patients. Pharmacopsychiat 18: 110–111

    Article  Google Scholar 

  • Valentino RJ, Foote SL, Aston-Jones G (1983) Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus. Brain Res 270: 363 – 367

    Article  PubMed  CAS  Google Scholar 

  • Waldmeier PC, Baumann PA, Hauser K, Maitre L, Storni A (1982) Oxaprotiline, a noradrenaline uptake inhibitor with an active and an inactive enantiomer. Biochem Pharmacol 31:2169–2176

    Article  PubMed  CAS  Google Scholar 

  • Wilens TE, Ritchie JC, Carroll BJ (1984) Comparison of plasma Cortisol and corticosterone in the dexamethasone suppression test for melancholia. Psychoneuroendocrinol 9: 45 – 55

    Article  CAS  Google Scholar 

  • Winokur A, Caroff SN, Amsterdam JD, Maislin G (1984) Administration of thyrotropin-releasing hormone at weekly intervals results in a diminished thyrotropin response. Biol Psychiat 5: 695–702

    Google Scholar 

Download references

Authors
  1. F. Holsboer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Psychiatrischen Universitätsklinik, Osianderstraße 22, D-7400, Tübingen, Deutschland

    Hans Heimann (Direktor) & Hans Jörg Gaertner (Oberarzt) (Direktor) &  (Oberarzt)

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Holsboer, F. (1986). Klinischer Nutzen psychoneuroendokrinologischer Untersuchungen. In: Heimann, H., Gaertner, H.J. (eds) Das Verhältnis der Psychiatrie zu ihren Nachbardisziplinen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70952-4_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-70952-4_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-16179-0

  • Online ISBN: 978-3-642-70952-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation